New heart mapping could make ablation more precise for lethal rhythm disorder

NCT ID NCT07573579

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new technique called Dynamic Voltage Mapping (DVM) to better identify scar tissue in the heart that causes ventricular tachycardia (VT), a life-threatening heart rhythm. The approach uses catheters to create a personalized electrical map, aiming to guide ablation more accurately. Researchers will enroll 40 adults with VT who already have an implantable defibrillator, comparing DVM-guided ablation to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Dynamic Voltage Mapping (a procedure using catheters to create a personalized electrical map of the heart)

What this could lead to

If successful, this mapping technique could help doctors more precisely destroy the heart tissue causing dangerous rhythms, potentially reducing the chance of VT returning after ablation.

What could go wrong

This is a small, early feasibility study with only 40 participants, so results may not apply to everyone. The technique may not prove better than standard care, and there are always risks with catheter procedures like bleeding or heart damage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA (VT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Liverpool Heart and Chest Hospital NHS Foundation Trust

    Liverpool, L14 3PE, United Kingdom

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact